[Treatment of craniopharyngiomas in children]
- PMID: 15227841
[Treatment of craniopharyngiomas in children]
Abstract
Purpose: The purpose of this article is to assess, in a 25-year retrospective study, the clinical outcome in children with craniopharyngioma.
Patient and methods: From 1978 to 2002, 12 children younger than 15-year-old underwent treatment with surgery and/or radiotherapy for craniopharyngioma. The clinical course and outcome were reviewed.
Results: The median age was 7.3 years (range, 3 to 12 years) at the time of initial surgical resection. With a mean follow-up period of 132 months (range, 29 to 255 months), 1 patient died of tumor progression due to malignant transformation at 205 months after the initial surgery and the overall outcome was good in 11 patients. Out of 12 patients 4 presented a recurrence of their tumor, 2 after an apparently gross total removal. Because of tumor recurrence, 2 received conventional radiation therapy and 3 received gamma knife radiosurgery. There was neither operative mortality nor major complication. All patients required hormonal replacement postoperatively.
Conclusions: The goal in the treatment of craniopharyngiomas is to achieve total removal without morbidity. Our results compared favorably with the previous reports in the literature. MRI follow-up should be performed even in patients whose primary tumor is resected "completely". Suitable combination of open surgery, conventional radiotherapy and gamma knife radiosurgery may result in optimal functional outcome. Recovery from postoperative pituitary dysfunction can be occasionally expected.
Similar articles
-
Successful surgical treatment of craniopharyngioma in very young children.J Neurosurg Pediatr. 2009 May;3(5):397-406. doi: 10.3171/2009.1.PEDS08401. J Neurosurg Pediatr. 2009. PMID: 19409019
-
Clinical outcome in children with recurrent craniopharyngioma after primary surgery.Cancer J. 2000 Nov-Dec;6(6):388-93. Cancer J. 2000. PMID: 11131489
-
Management of craniopharyngioma.Cancer J. 2001 Nov-Dec;7(6):516-20. Cancer J. 2001. PMID: 11769865
-
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409. doi: 10.1111/j.1365-2265.2005.02231.x. Clin Endocrinol (Oxf). 2005. PMID: 15807869 Review.
-
Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.J Neurosurg. 2007 Jan;106(1 Suppl):3-12. doi: 10.3171/ped.2007.106.1.3. J Neurosurg. 2007. PMID: 17233305 Review.
Cited by
-
Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.J Neurooncol. 2007 Jun;83(2):183-9. doi: 10.1007/s11060-006-9284-0. Epub 2007 Apr 5. J Neurooncol. 2007. PMID: 17410335
-
De novo malignant craniopharyngioma: case report and literature review.J Neurooncol. 2011 Jun;103(2):381-6. doi: 10.1007/s11060-010-0382-7. Epub 2010 Sep 3. J Neurooncol. 2011. PMID: 20814809 Review.
-
Sequential pathological changes during malignant transformation of a craniopharyngioma: A case report and review of the literature.Surg Neurol Int. 2015 Mar 30;6:50. doi: 10.4103/2152-7806.154274. eCollection 2015. Surg Neurol Int. 2015. PMID: 25883842 Free PMC article.
-
The cell-cycle kinetics of craniopharyngioma and its clinical significance.J Neurooncol. 2010 May;98(1):71-6. doi: 10.1007/s11060-009-0047-6. Epub 2009 Nov 24. J Neurooncol. 2010. PMID: 19937088
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical